Witkiewitz, Katie http://orcid.org/0000-0002-1086-3067
Kranzler, Henry R.
Hallgren, Kevin A.
Hasin, Deborah S.
Aldridge, Arnie P.
Zarkin, Gary A.
Mann, Karl F.
O’Malley, Stephanie S.
Anton, Raymond F.
Funding for this research was provided by:
National Institute on Alcohol Abuse and Alcoholism (R01AA022328, R01AA025309)
Article History
Received: 2 January 2020
Accepted: 18 October 2020
First Online: 12 November 2020
Compliance with Ethical Standards
:
: Dr. Kranzler is named as an inventor on PCT patent application #15/878,640 entitled “Genotype-guided dosing of opioid agonists,” filed January 24, 2018. Dr. Hasin is principal investigator of a study funded by inVentiv Health Consulting that combines support from Actavis, Inc.; Endo Pharmaceuticals; Janssen Pharmaceuticals, Inc.; Mallinckrodt, LLC; Pfizer, Inc.; Purdue Pharma, L.P.; Rhodes Pharmaceuticals, L.P.; Roxane Laboratories, Inc.; and Zogenix, Inc. Dr. O’Malley reports being a consultant or an advisory board member of Alkermes, Indivior, Mitsubishi Tanabe, and Opiant, and a NIDA Clinical Trials Network DSMB member with honorarium from the Emmes Corporation and non-financial support from Amygdala Neurosciences, Astra Zeneca, and Novartis. Dr. Anton has been a consultant in recent past for Insys, Allergan, and Life Epigenetics, has received honorarium from Alkermes for grant reviews and advisory board activities, and currently has grant funding from Laboratorio Farmaceutico CT. Dr. Hallgren reports personal fees from Pear Therapeutics, outside the submitted work. Drs. Witkiewitz, Kranzler, Mann, Hasin, O’Malley, Aldridge, Zarkin, and Anton are members of or have participated in meetings sponsored by the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative (ACTIVE Group), which over the time that this paper was developed was supported by Alkermes, Amygdala Neurosciences, Arbor Pharmaceuticals, Ethypharm, Indivior, Lundbeck, Mitsubishi, and Otsuka.
: The funders had no role in the design, analysis, interpretation, or publication of this study.